Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 55/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

100%

1 of 1 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
2(66.7%)
Phase 4
1(33.3%)
3Total
N/A(2)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT04909008Not ApplicableSuspended

Exercise Training to Improve Cardiopulmonary Hemodynamics in Heart Failure Patients

Role: collaborator

NCT05201014Active Not Recruiting

Cancer Survivor Cardiomyopathy Detection

Role: collaborator

NCT01999517Phase 4Completed

Contrast Nephropathy and Nitrates

Role: collaborator

NCT01025323Not ApplicableTerminated

Study of Hispanics to Assess Risk Prevention in Prehypertension

Role: lead

All 4 trials loaded